Back

Association of hydrochlorothiazide treatment compared to alternative diuretics with overall and skin cancer risk: a propensity-matched cohort study

26 August 2023 (09:24 - 09:42)
Organised by: Logo
Congress Presentation Part of: Challenges in hypertension management Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Felix Goetzinger

University Hospital Basel, Basel (Switzerland)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on pharmacotherapy in hypertension
Professor A. Pathak (Luxembourg, LU)
Slides Video
Presentation thumbnail
Effect of initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy on ambulatory blood pressure indices
Doctor J. Nolde (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
Estimated impact of timely guidelines-based initiation of dual-combination anti-hypertensive therapy on long-term cardiovascular outcomes in a population of 1.4 million individuals.
Professor A. Coca (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Evening anti-hypertensive dosing, blood pressure and cardiovascular events in hypertensive: Updated meta-analysis of 41 trials in 65,271 patients
Doctor A. Sunjaya (Jakarta, ID)
Abstract Slides Video

Access the full session

Session thumbnail
Challenges in hypertension management
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 09:24 CET
You may be interested in
thumbnail
Congress Session
Challenges in hypertension management
thumbnail
Congress Presentation
Association of hypertension and the risk of cancer: a study based on the UK Biobank
thumbnail
Congress Presentation
Comparison of cardiovascular outcomes between chlorthalidone and hydrochlorothiazide in hypertensive patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources